Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06446037 · ClinicalTrials.gov registry record · Early Phase 1
Assessment of Gesture Accuracy of a Prosthesis Control System
A Early Phase 1 study of Upper Limb Amputation Below Elbow (Injury), sponsored by Phantom Neuro.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT06446037 is a Early Phase 1 study of Upper Limb Amputation Below Elbow (Injury) that has completed, run by Phantom Neuro. The registered enrollment target is 11 participants, below the 86-participant average among 3 other Upper Limb Amputation Below Elbow (Injury) trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06446037, a Early Phase 1 study of Upper Limb Amputation Below Elbow (Injury), has completed, sponsored by Phantom Neuro.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is evaluating the performance of prosthesis control system, referred to as Phantom X, in able bodied individuals and individuals with upper limb amputation at the forearm level.
Conditions Studied
Interventions
- DEVICE Non-invasive EMG band instrumentation
Study Locations (1)
Texas
- Phantom Neuro Inc. Operational Headquarters - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-08-13 |
| Est. Completion | 2025-04-18 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06446037
The ClinicalTrials.gov registry entry for NCT06446037 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 3 other Upper Limb Amputation Below Elbow (Injury) trials with a reported enrollment target (87% lower). The listed sponsor is Phantom Neuro, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper Limb Amputation Below Elbow (Injury) appearing as the primary indexed condition, and to 1 intervention - of which Non-invasive EMG band instrumentation is the first listed.
NCT06446037 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06446037 about?
NCT06446037 is a clinical study titled "Assessment of Gesture Accuracy of a Prosthesis Control System". The study is evaluating the performance of prosthesis control system, referred to as Phantom X, in able bodied individuals and individuals with upper limb amputation at the forearm level.
What is the current status of trial NCT06446037?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2024-08-13. Estimated completion is 2025-04-18.
What conditions does trial NCT06446037 study?
This clinical trial studies the following conditions: Upper Limb Amputation Below Elbow (Injury).
What interventions are being tested in trial NCT06446037?
The interventions under investigation include: Non-invasive EMG band instrumentation (DEVICE).
Who is sponsoring clinical trial NCT06446037?
This trial is sponsored by Phantom Neuro, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06446037 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Upper Limb Amputation Below Elbow (Injury)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.